New Weight Loss Drug Retatrutide Shows Promising Clinical Trial Results | Retatrutide News

Retatrutide, a GLP-1 agonist developed by Eli Lilly, has shown promising results in a major clinical trial. This development could mark a significant ad...
Clinical Trials · October 12, 2026